{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:18:11Z","timestamp":1760980691325},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1989,12]]},"DOI":"10.1007\/bf01975176","type":"journal-article","created":{"date-parts":[[2005,7,31]],"date-time":"2005-07-31T06:10:25Z","timestamp":1122790225000},"page":"1093-1101","source":"Crossref","is-referenced-by-count":15,"title":["Quinolones and the gastrointestinal tract"],"prefix":"10.1007","volume":"8","author":[{"given":"B. E.","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01975176_CR1","first-page":"636","volume":"72","author":"H. C. Neu","year":"1988","unstructured":"Neu, H. C. Quinolones: a new class of antimicrobial agents with wide potential uses. Medical Clinics of North America 1988, 72: 636.","journal-title":"Medical Clinics of North America"},{"key":"BF01975176_CR2","doi-asserted-by":"crossref","unstructured":"Murray, B.: Impact of fluoroquinolones on the gastro-intestinal flora. Reviews of Infectious Diseases 11, Supplement 5: 1372\u20131378.","DOI":"10.1093\/clinids\/11.Supplement_5.S1372"},{"key":"BF01975176_CR3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.28.4.581","volume":"28","author":"J. S. Wolfson","year":"1985","unstructured":"Wolfson, J. S., Hopper, D. C. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 1985, 28: 581\u2013586.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR4","first-page":"253","volume":"11","author":"M. D. O'Hare","year":"1985","unstructured":"O'Hare, M. D., Felmingham, D., Ridgway, G. L., Grunebert, R. N. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens. Drugs and Experimental Clinical Research 1985, 11: 253\u2013257.","journal-title":"Drugs and Experimental Clinical Research"},{"key":"BF01975176_CR5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF01643966","volume":"14","author":"R. Vanhoof","year":"1986","unstructured":"Vanhoof, R., Hubrechts, J. M., Roebben, E., Nyssen, H. J., Nulens, E., Leger, J., De Schepper, N. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms. Infection 1986, 14: 294\u2013298.","journal-title":"Infection"},{"key":"BF01975176_CR6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.27.3.388","volume":"27","author":"H. Goossens","year":"1985","unstructured":"Goossens, H., De Mol, P., Coignau, H., Levy, J., Grados, O., Ghysels, G., Innocent, H., Butzler, J. P. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrobial Agents and Chemotherapy 1985, 27: 388\u2013392.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1128\/AAC.28.3.442","volume":"28","author":"J. G. Morris","year":"1985","unstructured":"Morris, J. G., Tenney, J. H., Drusano, G. L. In vitro susceptibility of pathogenicVibrio species to norfloxacin and six other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1985, 28: 442\u2013445.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0738-1751(88)90018-4","volume":"5","author":"A. L. Barry","year":"1988","unstructured":"Barry, A. L. In vitro activity of the fluoroquinolone compounds. Antimicrobic Newsletter 1988, 5: 69\u201376.","journal-title":"Antimicrobic Newsletter"},{"key":"BF01975176_CR9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/AAC.29.2.374","volume":"29","author":"M. Delmee","year":"1986","unstructured":"Delmee, M., Avesani, V. Comparative in vitro activity of seven quinolones against 100 clinical isolates ofClostridium difficile. Antimicrobial Agents and Chemotherapy 1986, 29: 374\u2013375.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/AAC.33.1.108","volume":"33","author":"A. E. Simor","year":"1989","unstructured":"Simor, A. E., Ferro, S., Low, D. E. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents againstCampylobacter pylori. Antimicrobial Agents and Chemotherapy 1989, 33: 108\u2013109.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/22.5.631","volume":"22","author":"D. J. Hardy","year":"1988","unstructured":"Hardy, D. J., Hanson, C. W., Hensey, D. M., Beyer, J. M., Fernandes, P. B. Susceptibility ofCampylobacter pylori to macrolides and fluoroquinolones. Journal of Antimicrobial Chemotherapy 1988, 22: 631\u2013636.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jac\/18.6.693","volume":"18","author":"P. B. Fernandes","year":"1986","unstructured":"Fernandes, P. B., Shipkowitz, N., Bower, R. R., Jarvis, K. P., Weisz, J., Chut, D. T. W. In vitro and in vivo potency of five new fluoroquinolones against anaerobic bacteria. Journal of Antimicrobial Chemotherapy 1986, 18: 693\u2013701.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF01646921","volume":"16","author":"C. Edlund","year":"1988","unstructured":"Edlund, C., Nord, C. E. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection 1988, 16: 8\u201312.","journal-title":"Infection"},{"key":"BF01975176_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/AAC.26.1.110","volume":"26","author":"R. D. Cofsky","year":"1984","unstructured":"Cofsky, R. D., du Bouhet, L., Landesman, S. H. Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 110\u2013111.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/00365548709032386","volume":"19","author":"C. Edlund","year":"1987","unstructured":"Edlund, C., Bergan, T., Josefsson, K., Solbert, R., Nord, C. E. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmaco-kinetics. Scandinavian Journal of Infectious Diseases 1987, 19: 113\u2013121.","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"BF01975176_CR16","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.31.11.1665","volume":"31","author":"N. Janin","year":"1987","unstructured":"Janin, N., Meugnier, H., Desnottes, J. F., Woehrle, R., Fleurette, J. Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers. Antimicrobial Agents and Chemotherapy 1987, 31: 1665\u20131668.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement 1","key":"BF01975176_CR17","first-page":"207","volume":"10","author":"J. P. Stahl","year":"1988","unstructured":"Stahl, J. P., Leclerq, P., Lefebvre, M. A., Yver, R., Bru, J. P., Letoublon, C., Fourtillan, J. B., Micoud, M. Distribution of ofloxacin into mesenteric lymph nodes. Reviews of Infectious Diseases 1988, 10, Supplement 1: 207\u2013208.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01975176_CR18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/AAC.29.6.1047","volume":"29","author":"S. Pecquet","year":"1986","unstructured":"Pecquet, S., Andremont, A., Tancrede, C. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human faecal flora. Antimicrobial Agents and Chemotherapy 1986, 29: 1047\u20131052.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-5347(17)49342-6","volume":"133","author":"A. J. Schaeffer","year":"1985","unstructured":"Schaeffer, A. J., Sisney, G. A. Efficacy of norfloxacin in urinary tract infections: biological effects on vaginal and fecal flora. Journal of Urology 1985, 133: 298\u2013300.","journal-title":"Journal of Urology"},{"key":"BF01975176_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02075258","volume":"9","author":"H. G. Vries-Hospers De","year":"1987","unstructured":"De Vries-Hospers, H. G., Welling, G. W., van der Waaij, D. Influence of quinolones on throat and faecal flora of healthy volunteers. Pharmaceutisch Weekblad 1987, 9: 41\u201344.","journal-title":"Pharmaceutisch Weekblad"},{"key":"BF01975176_CR21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0002-9343(87)90625-5","volume":"82","author":"E. J. C. Goldstein","year":"1987","unstructured":"Goldstein, E. J. C., Citron, D. M., Corrado, M. L. Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. American Journal of Medicine 1987, 82: 84\u201387.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/AAC.32.12.1869","volume":"32","author":"C. Edlund","year":"1988","unstructured":"Edlund, C., Lindqvist, L., Nord, C. E. Norfloxacin binds to human fecal material. Antimicrobial Agents and Chemotherapy 1988, 32: 1869\u20131874.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF02017617","volume":"6","author":"C. Edlund","year":"1987","unstructured":"Edlund, C., Lidbeck, A., Kager, L., Nord, C. E. Effect of enoxacin on colonic microflora of healthy volunteers. European Journal of Clinical Microbiology 1987, 6: 298\u2013300.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF01975176_CR24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/AAC.29.2.298","volume":"29","author":"T. Bergan","year":"1986","unstructured":"Bergan, T., Delin, C., Johansen, S., Kolstad, I. M., Nord, C. E., Thorsteinsson, S. B. Pharmacokinetics of ciprofloxacin and effects of repeated dosage on salivary and feacal microflora. Antimicrobial Agents and Chemotherapy 1986, 29: 298\u2013302.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.26.5.757","volume":"26","author":"W. Brumfitt","year":"1984","unstructured":"Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J. M. T., Iliffe, A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 757\u2013761.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01645437","volume":"13","author":"R. Enzensberger","year":"1985","unstructured":"Enzensberger, R., Shah, P. M., Knothe, H. Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection 1985, 13: 273\u2013275.","journal-title":"Infection"},{"key":"BF01975176_CR27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02013987","volume":"5","author":"H. A. Hold","year":"1986","unstructured":"Hold, H. A., Lewis, D. A., White, L. O., Bastable, S. Y., Reeves, D. S. Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. European Journal of Clinical Microbiology 1986, 5: 201\u2013205.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF01975176_CR28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/infdis\/152.1.104","volume":"152","author":"M. Rozenberg-Arska","year":"1985","unstructured":"Rozenberg-Arska, M., Dekker, A. W., Verhoef, J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. Journal of Infectious Diseases 1985, 152: 104\u2013107.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01975176_CR29","first-page":"336","volume":"82","author":"B. E. Scully","year":"1987","unstructured":"Scully, B. E., Jules, K., Chin, N-X., Neu, H. C. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin. American Journal of Medicine 1987, 82: 336\u2013338.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/AAC.31.1.124","volume":"31","author":"S. Pecquet","year":"1987","unstructured":"Pecquet, S., Andremont, A., Tancrede, C. Effect of ofloxacin on fecal bacteria in human volunteers. Antimicrobial Agents and Chemotherapy 1987, 31: 124\u2013125.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(87)90081-7","volume":"82","author":"P. M. Shah","year":"1987","unstructured":"Shah, P. M., Enzensberger, R., Glogau, O., Knothe, H. Influence of oral ciprofloxacin or ofloxacin on the fecal flora of healthy volunteers. American Journal of Medicine 1987, 82: 333\u2013338.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01963066","volume":"7","author":"C. Edlund","year":"1988","unstructured":"Edlund, C., Kager, L., Malmborg, A. S., Sjostedt, S., Nord, C. E. Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 135\u2013143.","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"BF01975176_CR33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9343(84)90250-X","volume":"76","author":"C. E. Nord","year":"1984","unstructured":"Nord, C. E., Kager, L., Heimdahl, A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. American Journal of Medicine 1984, 76: 99\u2013106.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR34","first-page":"99","volume":"11","author":"D. Waaij van der","year":"1983","unstructured":"van der Waaij, D. Colonization pattern of the digestive tract by potentially pathogenic microorganisms: colonization-controlling mechanisms and consequences for antibiotic treatment. Infection 1983, 11: 99\u2013160.","journal-title":"Infection"},{"key":"BF01975176_CR35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/155.3.377","volume":"155","author":"M. M. Levine","year":"1987","unstructured":"Levine, M. M. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. Journal of Infectious Diseases 1987, 155: 377\u2013389.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01975176_CR36","first-page":"1511","volume-title":"Internal medicine","author":"H. L. DuPont","year":"1987","unstructured":"DuPont, H. L. Gastrointestinal infections. In: Stein, J. H. (ed.): Internal medicine, Little, Brown and Co., Boston, 1987, p. 1511\u20131520."},{"key":"BF01975176_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0002-9343(87)90624-3","volume":"82","author":"H. L. DuPont","year":"1987","unstructured":"DuPont, H. L., Corrado, M. L., Sabbaj, J. Use of norfloxacin in the treatment of acute diarrheal disease. American Journal of Medicine 1987, 82: 79\u201383.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-106-2-216","volume":"106","author":"C. D. Ericsson","year":"1987","unstructured":"Ericsson, C. D., Johnson, P. C., DuPont, H. L., Morgan, D. R., Bitsura, J. A. M., de la Cabada, F. J. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. Annals of Internal Medicine 1987, 106: 216\u2013220.","journal-title":"Annals of Internal Medicine"},{"key":"BF01975176_CR39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-9343(87)90080-5","volume":"82","author":"H. E. T. Pichler","year":"1987","unstructured":"Pichler, H. E. T., Diridl, G., Stickler, K., Dietmar, W. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. American Journal of Medicine 1987, 82: 329\u2013332.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/AAC.30.5.671","volume":"30","author":"P. C. Johnson","year":"1986","unstructured":"Johnson, P. C., Ericsson, C. D., Morgan, D. R., DuPont, H. L., Cabada, F. J. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin. Antimicrobial Agents and Chemotherapy 1986, 30: 671\u2013674.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/20.4.563","volume":"20","author":"J. Wistrom","year":"1987","unstructured":"Wistrom, J., Norrby, S. R., Burman, L. G., Lundholm, R., Jellheden, B., Englund, G. Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. Journal of Antimicrobial Chemotherapy 1987, 20: 563\u2013574.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR42","first-page":"913","volume":"ii","author":"P. J. Moorhead","year":"1965","unstructured":"Moorhead, P. J., Parry, H. E. Treatment of Sonne dysentery. Lancet 1965, ii: 913\u2013915.","journal-title":"Lancet"},{"key":"BF01975176_CR43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/adc.48.4.305","volume":"48","author":"K. C. Haltalin","year":"1973","unstructured":"Haltalin, K. C., Nelson, J. D., Kusmiesz, H. T. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis. Archives of Diseases in Children 1973, 48: 305\u2013312.","journal-title":"Archives of Diseases in Children"},{"key":"BF01975176_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/inf.1981.13.issue-3.06","volume":"13","author":"H. B. Hansson","year":"1981","unstructured":"Hansson, H. B., Barkenius, G., Cronbert, S., Juhlin, I. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis. Scandinavian Journal of Infectious Diseases 1981, 13: 191\u2013193.","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"BF01975176_CR45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3476(88)80029-5","volume":"113","author":"M. A. Salam","year":"1988","unstructured":"Salam, M. A., Bennish, M. L. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. Journal of Pediatrics 1988, 113: 901\u2013907.","journal-title":"Journal of Pediatrics"},{"key":"BF01975176_CR46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/AAC.29.5.883","volume":"29","author":"F. Rogerie","year":"1986","unstructured":"Rogerie, F., Ott, D., Vandepitte, J., Verbist, L., Lemmens, P., Habiyaremye, I. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused byShigella dysenteriae type 1 in adults. Antimicrobial Agents and Chemotherapy 1986, 29: 883\u2013886.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR47","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/jac\/19.5.695","volume":"19","author":"P. Mol De","year":"1987","unstructured":"De Mol, P., Mets, T., Lagasse, R., Vandepitte, J., Mutwewingabo, A., Butzler, J.-P. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. Journal of Antimicrobial Chemotherapy 1987, 19: 695\u2013698.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR48","first-page":"55","volume":"48","author":"G. M. Ruiz-Palacios","year":"1986","unstructured":"Ruiz-Palacios, G. M. Norfloxacin in the treatment of bacterial enteric infections. Scandinavian Journal of Infectious Diseases 1986, 48: 55\u201363.","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"BF01975176_CR49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/AAC.29.2.185","volume":"29","author":"L. J. Goodman","year":"1986","unstructured":"Goodman, L. J., Kaplan, R. L., Petrak, R. M., Fliegelman, R. M., Taff, D., Walton, F., Penner, J. L., Trenholme, G. M. Effects of erythromycin and ciprofloxacin on chronic fecal excretion ofCampylobacter species in marmosets. Antimicrobial Agents and Chemotherapy 1986, 29: 185\u2013187.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR50","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/JCM.25.9.1807-1808.1987","volume":"25","author":"M. Altwegg","year":"1987","unstructured":"Altwegg, M., Burnens, A., Zollinger-Iten, J., Penner, J. L. Problems in identification ofCampylobacter jejuni associated with acquisition of resistance to nalidixic acid. Journal of Clinical Microbiology 1987, 25: 1807\u20131808.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01975176_CR51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01661308","volume":"14","author":"D. Tanphaichitra","year":"1986","unstructured":"Tanphaichitra, D., Sahaphong, S., Srimuang, S. Ofloxacin, a new quinolone, in the treatment of genitourinary and enteric infections. Infection 1986, 14: 321\u2013323.","journal-title":"Infection"},{"key":"BF01975176_CR52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jac\/21.5.681","volume":"5","author":"W.-L. Lo","year":"1988","unstructured":"Lo, W.-L. Ofloxacin in treatment of typhoid fever: a preliminary study. Journal of Antimicrobial Chemotherapy 1988, 5: 681\u2013682.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/155.4.833","volume":"155","author":"C. Carbon","year":"1987","unstructured":"Carbon, C., Weber, P., Levy, M., Boussougant, Y., Cerf., M. Short-term ciprofloxacin therapy for typhoid fever. Journal of Infectious Diseases 1987, 155: 883.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01975176_CR54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.28.1.128","volume":"28","author":"C. A. Ramirez","year":"1985","unstructured":"Ramirez, C. A., Bran, J. L., Mejia, C. R., Garcia, J. F. Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1985, 28: 128\u2013132.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01962337","volume":"7","author":"M. Hajji","year":"1988","unstructured":"Hajji, M., Mdaghri, N. E., Benbachir, M., El Filali, K. M., Himmich, H. Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 361\u2013363.","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"BF01975176_CR56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/157.6.1235","volume":"157","author":"C. Ferreccio","year":"1988","unstructured":"Ferreccio, C., Morris, J. G., Valdivieso, C., Prenzel, I., Sotomayor, V., Drusano, G. L., Levine, M. M. Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers. Journal of Infectious Diseases 1988, 157: 1235\u20131239.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01975176_CR57","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/infdis\/157.6.1221","volume":"157","author":"E. Gotuzzo","year":"1988","unstructured":"Gotuzzo, E., Guerra, J. G., Benavente, L., Palomino, J. C., Carrillo, C., Lopera, J., Delgado, F., Nalin, D. R., Sabbaj, J. Use of norfloxacin to treat chronic typhoid carriers. Journal of Infectious Diseases 1988, 157: 1221\u20131225.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01975176_CR58","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(86)91179-7","volume":"i","author":"A. Loffler","year":"1986","unstructured":"Loffler, A., Westphalen, H. G. Successful treatment of chronic salmonella excretor with ofloxacin. Lancet 1986, i: 1206.","journal-title":"Lancet"},{"key":"BF01975176_CR59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02014006","volume":"5","author":"G. Diridl","year":"1986","unstructured":"Diridl, G., Pichler, H., Wolf, D. Treatment of chronic salmonella carriers with ciprofloxacin. European Journal of Clinical Microbiology 1986, 5: 260\u2013261.","journal-title":"European Journal of Clinical Microbiology"},{"issue":"Supplement","key":"BF01975176_CR60","first-page":"25","volume":"24","author":"P. N. R. Heseltine","year":"1988","unstructured":"Heseltine, P. N. R., Causey, D. M., Appleman, M. D., Corrado, M. L., Leedom, J. M. Norfloxacin in the eradication of enteric infections in AIDS patients. European Journal of Cancer and Clinical Oncology 1988, 24, Supplement: 25\u201328.","journal-title":"European Journal of Cancer and Clinical Oncology"},{"key":"BF01975176_CR61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF01645442","volume":"13","author":"S. Esposito","year":"1985","unstructured":"Esposito, S., Gaeta, G. B., Galante, D., Barba, D. Successful treatment with ciprofloxacin ofSalmonella typhimurium infection in an immunocompromised host. Infection 1985, 13: 288.","journal-title":"Infection"},{"key":"BF01975176_CR62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/18.5.647","volume":"18","author":"M. J. Connolly","year":"1986","unstructured":"Connolly, M. J., Snow, M. H., Ingham, H. R. Ciprofloxacin treatment of recurrentSalmonella typhimurium septicaemia in a patient with acquired immune deficiency syndrome. Journal of Antimicrobial Chemotherapy 1986, 18: 647\u2013648.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR63","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jac\/16.5.667","volume":"16","author":"W. N. Patton","year":"1985","unstructured":"Patton, W. N., Smith, G. M., Leyland, M. J., Geddes, A. M. Multiply resistantSalmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 16: 667\u2013669.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.32.1.57","volume":"32","author":"H. Brunner","year":"1988","unstructured":"Brunner, H., Zeiler, H. J. Oral ciprofloxacin treatment forSalmonella typhimurium infection of normal and immunocompromised mice. Antimicrobial Agents and Chemotherapy 1988, 32: 57\u201362.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jac\/22.5.729","volume":"22","author":"C. A. M. McNulty","year":"1988","unstructured":"McNulty, C. A. M., Dent, J. C., Ford, G. A., Wilkinson, S. P. Inhibitory antimicrobial concentrations againstCampylobacter pylori in gastric mucosa. Journal of Antimicrobial Chemotherapy 1988, 22: 729\u2013738.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jac\/22.1.92","volume":"22","author":"J. W. Stone","year":"1988","unstructured":"Stone, J. W., Wise, R., Donovan, I. A., Gearty, J. Failure of ciprofloxacin to eradicateCampylobacter pylori from the stomach. Journal of Antimicrobial Chemotherapy 1988, 22: 92\u201393.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(86)92596-1","volume":"ii","author":"L. C. Preheim","year":"1986","unstructured":"Preheim, L. C., Cuevas, T. A., Roccaforte, J. S., Mellencamp, M. A., Bittner, M. J. Ciprofloxacin and antacids. Lancet 1986, ii: 48.","journal-title":"Lancet"},{"key":"BF01975176_CR68","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02013667","volume":"4","author":"G. Hoffken","year":"1985","unstructured":"Hoffken, G., Borner, K., Glatzel, P. D., Koeppe, P., Lode, H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. European Journal of Clinical Microbiology 1985, 4: 345.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF01975176_CR69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/00365528809091718","volume":"23","author":"A. M. Hirschl","year":"1988","unstructured":"Hirschl, A. M., Hentschel, E., Schutze, K., Nemec, H., Potzi, R., Gangl., A., Weiss, W., Pletschette, M., Stanek, G., Rotter, M. L. The efficacy of antimicrobial treatment inCampylobacter pylori-associated gastritis and duodenal ulcer. Scandinavian Journal of Gastroenterology 1988, 23: 76\u201381.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF01975176_CR70","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(87)91169-X","volume":"ii","author":"E. Bayerdorffer","year":"1987","unstructured":"Bayerdorffer, E., Simon, T., Bastlein, C., Ottenjann, R., Kasper, G. Bismuth\/ofloxacin combination for duodenal ulcer. Lancet 1987, ii: 1467\u20131468.","journal-title":"Lancet"},{"key":"BF01975176_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","volume":"106","author":"J. E. Karp","year":"1987","unstructured":"Karp, J. E., Merz, W. G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B. J., Bartlett, J. G., Saral, R., Burke, P. J. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. Annals of Internal Medicine 1987, 106: 1\u20136.","journal-title":"Annals of Internal Medicine"},{"key":"BF01975176_CR72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-106-1-7","volume":"106","author":"A. W. Dekker","year":"1987","unstructured":"Dekker, A. W., Rozenberg-Arkska, M., Verhoef, J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine 1987, 106: 7\u201312.","journal-title":"Annals of Internal Medicine"},{"key":"BF01975176_CR73","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0002-9343(86)90633-9","volume":"80","author":"D. J. Winston","year":"1986","unstructured":"Winston, D. J., Winston, G. H., Nakao, S. L., Gale, R. P., Champlin, R. E. Norfloxacin versus vancomycin\/polymyxin for prevention of infections in granulocytopenic patients. American Journal of Medicine 1986, 80: 884\u2013890.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR74","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(88)90062-9","volume":"84","author":"E. J. Bow","year":"1988","unstructured":"Bow, E. J., Rayner, E., Louie, T. J. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. American Journal of Medicine 1988, 84: 847\u2013854.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(87)90617-6","volume":"82","author":"D. J. Winston","year":"1987","unstructured":"Winston, D. J., Ho, W. G., Champlin, R. E., Karp, J., Bartlett, J., Finley, R. S., Joshi, J. H., Talbot, G., Levitt, L., Deresinski, S., Corrado, M. Norfloxacin for prevention of bacterial infections in granulocytopenic patients. American Journal of Medicine 1987, 82: 40\u201346.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR76","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-106-1-144","volume":"106","author":"L. S. Young","year":"1987","unstructured":"Young, L. S. The new fluorinated quinolones for infection prevention in acute leukemia. Annals of Internal Medicine 1987, 106: 144\u2013146.","journal-title":"Annals of Internal Medicine"},{"key":"BF01975176_CR77","first-page":"902","volume":"36","author":"E. Gluckman","year":"1988","unstructured":"Gluckman, E., Cavazzana, M., Devergie, A., Meletis, J., Arlet, G., Perol, Y., Boiron, M. Prevention des infections bacteriennes apres greffe de moelle osseuse par antibiotiques oraux a large spectre absorbables (pefloxacine, penicilline) ou non absorbables (cephalosporine, gentamicine, bacitracine). Pathologie Biologie 1988, 36: 902\u2013906.","journal-title":"Pathologie Biologie"},{"issue":"Supplement 1","key":"BF01975176_CR78","first-page":"5","volume":"24","author":"J. E. Karp","year":"1988","unstructured":"Karp, J. E., Dick, J. D., Merz, W. G. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient. European Journal of Cancer and Clinical Bacteriology 1988, 24, Supplement 1: 5\u201313.","journal-title":"European Journal of Cancer and Clinical Bacteriology"},{"key":"BF01975176_CR79","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01644312","volume":"16","author":"G. Maschmeyer","year":"1988","unstructured":"Maschmeyer, G., Haralambie, E., Gaus, W., Kern, W., Dekker, A. W., De Vries-Hospers, H. G., Sizoo, W., Konig, W., Gutzler, F., Danenen, S. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection 1988, 16: 98\u2013104.","journal-title":"Infection"},{"key":"BF01975176_CR80","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/21.5.647","volume":"21","author":"G. M. Smith","year":"1988","unstructured":"Smith, G. M., Leyland, M. J., Farrell, I. D., Geddes, A. M. A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients. Journal of Antimicrobial Chemotherapy 1988, 21: 647\u2013655.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/18.Supplement_D.165","volume":"18","author":"G. M. Smith","year":"1986","unstructured":"Smith, G. M., Leyland, M. J., Farrell, I. D., Geddes, A. M. Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. Journal of Antimicrobial Chemotherapy 1986, 18: 165\u2013174.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01975176_CR82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01647222","volume":"15","author":"W. Kern","year":"1987","unstructured":"Kern, W., Kurrle, E., Vanek, E. Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 1987, 15: 427\u2013432.","journal-title":"Infection"},{"key":"BF01975176_CR83","first-page":"641","volume":"13","author":"C. Esposito","year":"1987","unstructured":"Esposito, C., Barba, D., Galante, D., Gaeta, G. B., Laghezza, O. Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy (PSE). Drugs in Experimental Clinical Research 1987, 13: 641\u2013646.","journal-title":"Drugs in Experimental Clinical Research"},{"key":"BF01975176_CR84","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01647742","volume":"15","author":"S. Esposito","year":"1987","unstructured":"Esposito, S., Galante, D., Laghezza, O., Barba, D., Gaeta, G. B. Rapid improvement of hepatic encephalopathy associated with oral ciprofloxacin treatment. Infection 1987, 15: 364\u2013365.","journal-title":"Infection"},{"key":"BF01975176_CR85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00542200","volume":"32","author":"M. Dan","year":"1987","unstructured":"Dan, M., Verbin, N., Gorea, A., Nagar, H., Berger, S. A. Concentrations of ciprofloxacin in human liver, gallbladder, and bile after oral administration. European Journal of Clinical Pharmacology 1987, 32: 217\u2013218.","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF01975176_CR86","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/AAC.32.7.982","volume":"32","author":"M. F. Parry","year":"1988","unstructured":"Parry, M. F., Smego, D. A., Digiovanni, M. A. Hepatobiliary kinetics and excretion of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1988, 32: 982\u2013985.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR87","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.31.2.352","volume":"31","author":"M. Dan","year":"1987","unstructured":"Dan, M., Serour, F., Gorea, A., Levenberg, A., Krispin, M., Berger, S. A. Concentration of norfloxacin in human gallbladder tissue and bile after single-dose oral administration. Antimicrobial Agents and Chemotherapy 1987, 31: 352\u2013353.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01975176_CR88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-198700341-00010","volume":"34","author":"A. Kazmierczak","year":"1987","unstructured":"Kazmierczak, A., Pechinot, A., Duez, J-M., Haas, O., Favre, J-P. Biliary tract excretion of ofloxacin in man. Drugs 1987, 34: 39\u201343.","journal-title":"Drugs"},{"key":"BF01975176_CR89","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01650766","volume":"16","author":"C. J. Chrysanthopoulos","year":"1988","unstructured":"Chrysanthopoulos, C. J., Skoutelis, A. T., Starakis, J. C., Arvaniti, A., Bassaris, H. P. Use of ciprofloxacin in biliary sepsis. Infection 1988, 16: 249.","journal-title":"Infection"},{"key":"BF01975176_CR90","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(87)90087-8","volume":"82","author":"C. J. Chrysanthopoulos","year":"1987","unstructured":"Chrysanthopoulos, C. J., Skoutelis, A. T., Starakis, J. C., Anastassiou, E. D., Bassaris, H. P. Use of intravenous ciprofloxacin in respiratory tract infections and biliary sepsis. American Journal of Medicine 1987, 82: 357\u2013359.","journal-title":"American Journal of Medicine"},{"key":"BF01975176_CR91","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(87)90663-5","volume":"i","author":"R. H. J. Houwen","year":"1987","unstructured":"Houwen, R. H. J., Bijleveld, C. M. A., de Vries-Hospers, H. G. Ciprofloxacin for cholangitis after hepatic portoenterostomy. Lancet 1987, i: 1367.","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01975176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01975176\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01975176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T13:20:00Z","timestamp":1586352000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01975176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["BF01975176"],"URL":"https:\/\/doi.org\/10.1007\/bf01975176","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,12]]}}}